August 23, 2023
Today, JLI is announcing a company restructuring aimed at reducing our operating costs and positioning us to continue to advance our mission during a…
July 19, 2023
Juul Labs today announced the submission of the first Premarket Tobacco Product Application (PMTA) for the company’s next-generation vapor platform to the U.S. Food and Drug Administration (FDA).
April 17, 2023
Resolution of issues from the company’s past and its historical legal challenges has remained a critical priority to secure certainty for our future. While…
April 12, 2023
This settlement with seven state attorneys general represents another critical part in our ongoing commitment to resolve issues from the company’s past. The terms…
April 10, 2023
This settlement with the West Virginia Attorney General represents yet another step in Juul Labs’ ongoing commitment to resolve issues from the company’s past….
March 3, 2023
The return of Altria’s equity stake and termination of underlying agreements affords us full strategic freedom – we are no longer limited by the…
December 6, 2022
As of today, Juul Labs has reached settlements with plaintiffs in the federal multidistrict litigation (MDL) and related “JUUL Labs Product Cases” (JCCP) that…
October 21, 2022
Today, Juul Labs, Inc. (JLI) posted its administrative appeal of the marketing denial order (MDO) issued by the Food and Drug Administration (FDA), which…
September 29, 2022
Joe Murillo delivers keynote remarks at the Global Tobacco & Nicotine Forum 2022.
September 6, 2022
This settlement with 34 states and territories is a significant part of our ongoing commitment to resolve issues from the past. The terms of…